Home
Diabetes News
Diabetes Research

4 Diabetes

Menu

Home
Diabetes News
Diabetes Research

Home
Diabetes News
Diabetes Research

Diabetes Research

Comparing semaglutide and canagliflozin for patients with Type 2 diabetes

Comparing semaglutide and canagliflozin for patients with Type 2 diabetes

Tweet Pin It

Related Posts

Failed Genetic Protection: Type 1 Diabetes in the Presence of HLA-DQB1*06:02

Dextran Sulfate Protects Pancreatic β-Cells, Reduces Autoimmunity, and Ameliorates Type 1 Diabetes

GLP-1 receptor agonists for diabetes: a review of the cardiovascular, kidney and mortality outcomes

How effective and safe is non-insulin drug evogliptin for patients with type 2 diabetes?

Erratum. Comparison of Kidney Transcriptomic Profiles of Early and Advanced Diabetic Nephropathy Reveals Potential New Mechanisms for Disease Progression. Diabetes 2019;68:2301–2314

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

Popular Posts

Caring for the Young with Type 1 Diabetes
Dean Stapple: Living with type 1 diabetes in the coronavirus world
Abbott and Tandem Partner to Combine FreeStyle Libre with t:slim Insulin Pump
How Can I Help?
Statement of Retraction. Lucia Garcia-Guerra, Iria Nieto-Vázquez, Rocio Vila-Bedmar, María Jurado-Pueyo, Guillermo Zalba, Javier Díez, Cristina Murga, Sonia Fernández-Veledo, Federico Mayor, and Margarita Lorenzo. G Protein–Coupled Receptor Kinase 2 Plays a Relevant Role in Insulin Resistance and Obesity. Diabetes 2010;59:2407–2417. https://doi.org/10.2337/db10-0771

Our Site

Home
Affiliate Disclosure
Contact Us
Digital Millennium Copyright Act Notice
Terms Of Use
Amazon Affiliate Disclaimer
Anti Spam Policy
Medical Disclaimer
Privacy Policy
Home

4 Diabetes Copyright © 2021.